Brown & Brown’s second quarter results for 2026 fell short of market revenue expectations, but sales still rose 30.4% year on year to $1.68 billion. Management attributed performance to strong contingent commissions, effective integration of acquisitions, and ongoing enhancements to its sales and underwriting processes. CEO J. Powell Brown emphasized, “Our enhanced go-to-market sales model is building momentum with newly aligned teams collaborating, developing opportunities, and generating incremental new business wins.” The company also noted progress in controlling expenses, even as operating margin declined year-over-year, and highlighted solid cash flow generation and share repurchases as additional contributors to the quarter’s outcomes.

Is now the time to buy BRO? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Brown & Brown’s Q2 Earnings Call

• Michael Zaremski (BMO Capital Markets) asked about the timing and sustainability of Accession’s revenue and margin contributions. CFO R. Watts clarified that revenue seasonality is expected and margins should remain stable, with earnout-related cash flow impacts being one-time in nature.
• Charles Peters (Raymond James) questioned the impact of increased competition from managing general agents (MGAs) on specialty distribution growth. CEO J. Powell Brown acknowledged pricing pressure but stressed disciplined underwriting and a broader, more balanced risk portfolio.
• Elyse Greenspan (Wells Fargo) asked about hiring activity and its impact on organic growth. Brown explained that ongoing hiring is part of standard operations and that any substantial investments in new talent would be explicitly disclosed.
• Robert Cox (Goldman Sachs) inquired about margin guidance and the absorption of AI-related costs. Watts reiterated that technology investments are being offset by cost reallocation, and synergy targets remain unchanged, with no current plans for additional tech spending.
• Taylor Scott (Barclays) asked about expansion efforts in Europe. Brown detailed investments in hiring and capabilities for wholesale and programs businesses, citing London as a focus area for future organic growth.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be monitoring (1) the pace and impact of AI adoption across sales and underwriting workflows, (2) realization of cost synergies and integration benefits from the Accession acquisition, and (3) trends in contingent commissions and organic growth as insurance market competition intensifies. The effectiveness of capital allocation between share repurchases, technology investment, and future M&A will also be important for long-term performance.

Brown & Brown currently trades at $70.40, up from $69.70 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.